Abrdn PLC Legend Biotech Corp Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Abrdn PLC holds 33,729 shares of LEGN stock, worth $1.35 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,729

Previous 16,033 110.37%

Holding current value

$1.35 Million

Previous $710,000 131.41%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$43.55 - $59.88 $770,660 - $1.06 Million	17,696 Added 110.37%	33,729 $1.64 Million
Q2 2024 Aug 09, 2024	BUY	$39.5 - $57.22 $97,328 - $140,990	2,464 Added 18.16%	16,033 $710,000
Q1 2024 May 08, 2024	SELL	$55.06 - $69.99 $117,387 - $149,218	-2,132 Reduced 13.58%	13,569 $761,000
Q4 2023 Jan 31, 2024	BUY	$57.25 - $69.74 $139,747 - $170,235	2,441 Added 18.41%	15,701 $944,000
Q3 2023 Nov 06, 2023	SELL	$63.16 - $76.5 $147,983 - $179,239	-2,343 Reduced 15.02%	13,260 $890,000
Q2 2023 Jun 20, 2024	BUY	$46.28 - $75.01 $125,048 - $202,677	2,702 Added 20.94%	15,603 $1.08 Million
Q2 2023 Aug 04, 2023	BUY	$46.28 - $75.01 $125,048 - $202,677	2,702 Added 20.94%	15,603 $1.08 Million
Q1 2023 Jun 20, 2024	SELL	$43.42 - $57.37 $28,830 - $38,093	-664 Reduced 4.89%	12,901 $622,000
Q1 2023 Apr 28, 2023	SELL	$43.42 - $57.37 $28,830 - $38,093	-664 Reduced 4.89%	12,901 $622,000
Q4 2022 Jun 20, 2024	SELL	$38.8 - $55.46 $155 - $221	-4 Reduced 0.03%	13,565 $677,000
Q4 2022 Feb 09, 2023	BUY	$38.8 - $55.46 $154,812 - $221,285	3,990 Added 41.67%	13,565 $677,000
Q3 2022 Nov 10, 2022	BUY	$38.15 - $57.1 $161,069 - $241,076	4,222 Added 78.87%	9,575 $391,000
Q2 2022 Aug 05, 2022	BUY	$33.54 - $55.0 $179,539 - $294,415	5,353 New	5,353 $295,000

Others Institutions Holding LEGN

# of Institutions

205

Shares Held

74.5M

Call Options Held

371K

Put Options Held

387K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $6.7B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account